Last updated: May 28, 2026
Ayuna (Drug) suppliers: who manufactures, licenses, and distributes the product for pharmacies and hospitals?
No complete, source-backed answer can be produced because “Ayuna” is an ambiguous drug name in public regulatory and commercial databases (it is used as a brand name in multiple jurisdictions/contexts, and may refer to different active ingredients). Without an unambiguous identification of the specific Ayuna product (active ingredient, dosage form, strength, and marketing authorization holder), supplier lists would be speculative and materially unreliable.
What suppliers make Ayuna (manufacturers and contract manufacturers)?
No source-confirmed supplier roster can be delivered without correct product identity (active ingredient and dosage form).
Which CDMOs or API makers produce the active ingredient for Ayuna?
No source-confirmed API/CDMO mapping can be provided without product identity.
Which finished-dose manufacturing sites produce Ayuna tablets, capsules, injections, or other dosage forms?
No source-confirmed manufacturing-site listing can be provided without product identity.
What is the Orange Book status of Ayuna and who holds the US NDA?
No Orange Book status and no US NDA holder can be listed without the specific Ayuna drug identity.
Which ANDAs list Ayuna as the reference product?
No ANDA filing list can be provided without product identity.
Are there Paragraph IV challenges tied to Ayuna?
No Paragraph IV challenge dataset can be provided without product identity.
Who are Ayuna’s marketing authorization holder and distributors by country?
No country-by-country marketing and distribution roster can be delivered without the specific Ayuna product and jurisdiction.
Which wholesalers distribute Ayuna to hospitals and pharmacies?
No wholesaler list can be produced without product identity.
Which procurement channels sell Ayuna under tender contracts?
No tender/procurement supplier mapping can be produced without product identity.
Which companies supply Ayuna to government programs and major hospital systems?
No source-backed payer/provider contracting supplier mapping can be produced without product identity.
What GPO or group purchasing organizations list Ayuna?
No GPO listing can be provided without product identity.
How do Ayuna’s suppliers compare across active ingredient, dosage form, and pack size?
No comparative supplier analysis can be produced without the specific Ayuna product specification.
Key Takeaways
No high-confidence supplier, NDA holder, CDMO, API maker, distributor, or Orange Book/ANDA mapping can be produced for “Ayuna” because the drug is not uniquely identifiable from the provided input.
FAQs
- Which contract manufacturing organizations produce Ayuna finished dosage forms?
- Who is the US NDA holder for Ayuna and what is its Orange Book listing?
- Are there ANDA or biosimilar competitors for Ayuna with Paragraph IV filings?
- Which API manufacturers supply the active ingredient for Ayuna?
- Which distributors and hospital supply channels handle Ayuna in specific countries?
